Diabetes Research with Bios Life
Bios Life™ is a natural formulation that protects the body from the damage that can be caused by glucose and insulin spikes by delaying gastric emptying and lowering postprandial blood sugar. Simply put, when patients take Bios Life™ shortly before a meal, it creates a gel fiber matrix in the stomach. As the gel moves through the intestinal tract, food gets trapped inside it for short periods of time. This lowers the rate at which food is absorbed, thereby extending the time over which blood-sugar levels rise and fall. With this more gradual process, the average blood-sugar level remains lower throughout the day, stabilizing both blood glucose and insulin at a healthy and acceptable plateau.
Bios Life™ is easy to use and safe for long-term usage. It's simple to incorporate into a daily routine, which can lead to higher compliance. Each serving contains a patented, scientifically-formulated matrix of fibers, vitamins, and anti-oxidants which the body needs daily.
Bios Life 2™ proved effective in a clinical trial conducted by Independent Certified Diabetes Educators working with Diabetes in Control that was presented at the 2001 American Association of Certified Diabetes Educators (AADE) conference.
Bios Life C™ and Bios Life SLIM™ provides the same benefits as Bios Life 2™ to protect the body from uncontrolled blood glucose.
Click here for results from Fiber Supplementation Study.
This independent group studied diabetic patients for three months and gave them Bios Life 2™ twice daily before meals.
- Average reduction in postprandial 3 blood glucose of 17.2%.
- Average reduction of fasting blood glucose of 17% .
- Average reduction of total cholesterol of 17% .
- Average reduction of HbA1c of 15.2% in the first three months of usage. (HbA1c is an indicator of average blood sugar levels.)
- Average drop in blood pressure of 5% .
- Average drop in body weight of 4% (8 pounds).
- Average drop in triglycerides of 42% .
- Average increase in HDL cholesterol of 6%.
Note: When the vascular endpoints are averaged, the study shows an overall reduction in macro vascular endpoints of 18%. And it shows an overall reduction of micro vascular endpoints of 17%.
References: Freed, S. H.; Joffe, D .J. "The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Diabetes." Diabetes in Control, Issue 15 (1): 12-18 2000 Aug
Bell, D. S. "Importance of postprandial glucose control." South Medical Journal. 2001 Aug; 94(8):804-9
Click here for additional reports on diabetes research with Bios Life C™.
Click here to view the poster displaying the results of the effect of Bios Life™ on the control of Diabetes.